Tiny magnetic robots may soon cure sinus infections from the inside, no drugs, no surgery. Are we ready to trust machines in ...

Brad Spellberg, MD, urges rethinking the ‘finish the course’ dogma for antibiotics: Extra days may do more harm than good.

If an intestinal inhabitant such as the bacterium Escherichia coli (E. coli) becomes resistant to many antibiotics, it can ...

Mumbai-headquartered drugmaker Cipla Ltd is bolstering its focus on a pipeline of drugs to fight infections caused by ...

Storied Japanese pharma Shionogi is upping its arsenal in the fight against antibiotic resistance. | Storied Japanese pharma ...

As I head into my 25th year of working as a clinical infectious diseases pharmacist, one of the most important working relationships of my career is with the infection prevention department.

While the risk of infection after primary THA has been reduced to approximately 1% in most cases, [4,5,7,8] there remains a substantial percentage of patients who became reinfected after two-stage ...

Antibiotics specialist Bioversys AG has sealed a potential CHF529 million (US$667.5 million) deal with Shionogi Co. Ltd., in which they will work together on novel ansamycins for treating ...

New research suggests that a class of antibiotics commonly used in poultry and other food-producing animals, but not in ...

Dr Bhasha Mukherjee has shared why she will not give out antibiotics to 'pushy' patients – and the Miss World winner and NHS ...

HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...